Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma Multiforme through de-repression of Bcl-xL translation

Glioblastoma multiforme (GBM) is the most common and aggressive form of tumor of the central nervous system. Despite significant efforts to improve treatments, patient survival rarely exceeds 18 months largely due to the highly chemoresistant nature of these tumors. Importantly, misregulation of the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Liwak, Urszula, Jordan, Lindsay E., Von-Holt, Sally Davidson, Singh, Poonam, Hanson, Jennifer E.L., Lorimer, Ian A., Roncaroli, Federico, Holcik, Martin
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2013
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3824522/
https://ncbi.nlm.nih.gov/pubmed/23965755
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky